Archive for category: Special Report

Building a Compliant, Scalable Cold Chain from Clinical to Commercial

The pharmaceutical cold chain has never been more demanding. Biologics, monoclonal antibodies, GLP-1 therapies, and an expanding pipeline of temperature-sensitive products are placing requirements on cold chain infrastructure that far exceed what was standard a decade ago. The products are more complex, the regulatory expectations are higher, and the consequences of a cold chain failure — excursion, product loss, regulatory action — have never been more severe.

This report addresses what it takes to build a pharmaceutical cold chain that is compliant today and scalable through commercial growth — and where the gaps most commonly appear.

The Cost of Getting It Wrong

An estimated 20% of temperature-sensitive healthcare products are damaged or degraded during distribution — not because of product failures, but because of cold chain failures. The financial cost is significant. For high-value biologics, a single batch loss can represent hundreds of thousands of dollars. For personalized therapies and investigational products, the consequences extend beyond product replacement.

What makes pharmaceutical cold chain failures particularly costly is where they tend to occur: not within a single provider’s operation, but at the handoffs between providers. Between the international freight forwarder and the customs broker. Between customs clearance and the warehouse. Between the warehouse and the final-mile carrier.

Every gap between vendors is a gap in accountability — and a gap in the temperature record. A customs hold of 48 or 72 hours on a refrigerated shipment is not just a delay. Depending on the product’s stability profile and the packaging system’s validated hold time, it may be a product loss event. Yet most importers manage their freight forwarder and their customs broker as separate relationships, with no single party owning the temperature record across the clearance process.

The most preventable cold chain failures are not the dramatic ones. They are the quiet accumulation of uncontrolled handoffs between vendors who each own their segment and nobody owns the gaps between them.

What a Resilient Cold Chain Actually Requires

Validated Temperature Control

The temperature requirements of modern pharmaceutical products span a defined spectrum. The ranges most commonly required across pharmaceutical and biotech supply chains are:

• Controlled Room Temperature (15–25°C): standard for many finished drug products, APIs, and medical devices
• Refrigerated (2–8°C): required for biologics, vaccines, insulin, most monoclonal antibodies, and GLP-1 therapies
• Frozen (-20°C): required for certain biologics, vaccines, and research materials

A 3PL that can only offer one or two validated temperature ranges becomes a constraint as a product portfolio grows. Validated storage is not just about having refrigeration — it requires documented qualification of each zone, calibrated monitoring equipment, defined alarm thresholds, and a written response protocol for any deviation.

Continuous Monitoring and Documented Response

Temperature monitoring is not a passive function. It requires continuous data logging, immediate alert capability, and the ability to produce a complete, unbroken temperature record for any shipment or storage event on demand. For pharmaceutical companies operating under FDA oversight, this documentation is evidence — evidence that the cold chain performed as required and that any deviation was identified, assessed, and resolved through a documented CAPA process.

The distinction between a temperature excursion and a reportable deviation often comes down to how quickly the event was detected and how completely it was documented. Real-time monitoring with immediate alerts is not a feature — it is a regulatory expectation.

Compliance That Extends Through Import and Transport

A cold chain that is cGMP-compliant in the warehouse but uncontrolled during customs clearance or domestic transport is not a cold chain. It is a compliant segment surrounded by risk.

For pharmaceutical companies importing temperature-sensitive product from international manufacturers — the majority of biologics and APIs in the U.S. market — the customs clearance process is one of the most significant cold chain risk points in the supply chain. The only structural solution is to ensure that the party clearing customs and the party receiving the product into controlled storage are not operating as separate vendors, but as an integrated team with shared accountability for the temperature record.

Scalability from Clinical to Commercial

The choice of logistics partner at the clinical stage carries more weight than most companies recognize at the time they make it. A provider whose quality systems, facility capabilities, and distribution infrastructure already meet commercial-scale FDA requirements eliminates a significant operational and regulatory transition when approval comes. The product moves from clinical to commercial storage within the same validated environment, under the same quality system, without requalification.

That continuity is not just operationally convenient. It maintains documentation continuity, preserves the compliance record, and reduces the risk of introducing new variables into the supply chain during the highest-stakes period of a product’s commercial lifecycle.

Cold Chain Capability: What to Look For in a 3PL Partner

Bridging Clinical and Commercial: The Continuity Advantage

In many organizations, the transition from clinical supply chains to commercial distribution is one of the most logistically disruptive events in a product’s lifecycle. Trial logistics vendors often lack the scale or regulatory infrastructure required for national commercial distribution. Large commercial distributors that don’t specialize in regulated pharmaceuticals may lack the documentation rigor and handling precision that early-phase clinical operations require.

An integrated cold chain model — where one partner manages clinical material storage, just-in-time site distribution, and commercial-scale warehousing and fulfillment from the same validated facility — eliminates that transition risk. There are no new vendor qualifications, no gaps in the chain-of-custody record, and no period of supply chain uncertainty while the commercial logistics infrastructure is being stood up.

The questions worth asking when evaluating a cold chain partner for clinical-stage work are the same questions worth asking for commercial distribution: Is the facility FDA registered? Are the temperature zones validated and continuously monitored? Does the quality system meet cGMP requirements? Is there in-house customs brokerage capability for internationally sourced product? If those boxes are checked at the clinical stage, the commercial transition becomes a volume increase rather than an infrastructure overhaul.

How Euro-American Worldwide Logistics Supports the Pharmaceutical Cold Chain

Euro-American Worldwide Logistics operates a 45,000 square foot FDA registered, cGMP-compliant 3PL facility in Worcester, Massachusetts — 40 miles west of Boston, adjacent to Worcester Regional Airport, and at the center of one of the world’s most concentrated life sciences ecosystems.

Our cold chain capabilities include validated 2–8°C and 15–25°C storage across 25,000 square feet of temperature-controlled space, 24/7 monitoring with real-time alert systems, ISO-9001 certified quality controls, and CTPAT-certified security throughout the facility. Our in-house licensed U.S. Customs Brokerage team operates within the same facility as our warehouse — so internationally sourced pharmaceutical product moves directly from CBP clearance into controlled temperature storage without a vendor handoff or a gap in the temperature record.

We also provide GxP-compliant air and ocean freight forwarding through Worcester Regional Airport and Logan International, domestic distribution throughout the Northeast, and full chain-of-custody documentation from international origin through final delivery.

For pharmaceutical, biotech, and medical device companies that need a logistics partner capable of supporting their supply chain from first import through commercial scale — we are ready to talk. Contact us today.

Background: Why IEEPA Refunds Are Available

On February 20, 2026, the U.S. Supreme Court ruled that the International Emergency Economic Powers Act (IEEPA) does not authorize the President to impose tariffs. As a result, tariffs collected under IEEPA — including the reciprocal tariffs announced in April 2025 and the country-specific measures imposed on Canada, Mexico, and China — were invalidated.

Following the ruling, the U.S. Court of International Trade (CIT) ordered CBP to issue refunds for duties collected under those invalidated tariffs. CBP estimated that approximately 330,000 importers paid roughly $166 billion in IEEPA duties — with about $127 billion, covering approximately 82% of entries, eligible for refund through the initial system rollout.

To manage the volume and complexity of processing refunds at that scale, CBP developed a new electronic system rather than handling claims entry by entry through existing processes.

What Is CAPE?

CAPE stands for Consolidated Administration and Processing of Entries. It is a new functionality built within CBP’s existing Automated Commercial Environment (ACE) portal, designed specifically to process IEEPA duty refunds at scale.

CAPE launched on April 20, 2026. As of that date, it became the exclusive mechanism for submitting IEEPA refund claims. Post Summary Corrections (PSCs) can no longer be used to request IEEPA refunds. Importers and authorized customs brokers who want to recover duties paid under invalidated IEEPA tariffs must go through CAPE.

CBP will not proactively issue refunds. Importers must affirmatively file a CAPE Declaration to receive a refund. If no claim is submitted, no refund will be issued.

How the CAPE Process Works

The filing process is straightforward in structure. The importer of record (IOR) or the licensed customs broker who originally filed the entries logs into the ACE Portal and navigates to the new CAPE tab. From there, they upload a comma-separated values (CSV) file — called a CAPE Declaration — listing the entry numbers for which a refund is being requested.

Each CAPE Declaration can include up to 9,999 entry numbers. Importers or brokers with more entries than that can file multiple CAPE Declarations. No additional information beyond the entry numbers is required in the CSV file.

Once submitted, ACE runs two rounds of validation: first checking the CAPE Declaration file itself for formatting and authorization, then checking each individual entry to confirm eligibility. For entries that pass both validations, ACE removes the applicable IEEPA HTS Chapter 99 codes from the entry summary and recalculates duties as if the IEEPA charges were never assessed. The difference becomes the refund amount.

Refunds are disbursed electronically via ACH — direct deposit to a bank account registered in ACE. CBP will not issue refunds by check. Importers who have not yet enrolled in ACH refunds through ACE must do so before a refund can be released. Note that having ACH set up for duty payments is not sufficient — a separate enrollment for ACH refunds is required.

CBP has indicated that valid refunds will generally be issued within 60 to 90 days of CAPE Declaration acceptance, including statutory interest, subject to standard compliance review.

One Important Note on Offsets

CBP will apply “netting” to refund calculations. If an importer has underpayments in other duty programs, CBP may offset those amounts against the IEEPA refund before disbursement. CBP may also divert refunds to cover existing fixed and undisputed debts owed to the U.S. government. Importers should account for this possibility when estimating expected refund amounts.

Phase 1 Eligibility: What’s In and What’s Out

CAPE is being rolled out in phases. Phase 1, which launched April 20, is limited to lower-complexity entries. Not every entry with IEEPA duties is eligible in this first phase.

Entries excluded from Phase 1 — including those more than 80 days past liquidation, entries with unresolved reconciliation flags, and AD/CVD entries with issued liquidation instructions — may be addressed in future CAPE phases. CBP has not yet announced a timeline for Phase 2.

For entries with unresolved protests, importers can request removal of the suspended protest status from their CBP processing center, then withdraw and resubmit through CAPE once the suspension is lifted.

What You Need Before Filing

Before submitting a CAPE Declaration, importers and brokers should confirm the following are in place:

• ACE Portal account: the IOR or authorized broker must have an active ACE Portal account. Instructions for establishing an account are available on CBP’s IEEPA refund page
• ACH refund enrollment: bank account information for refunds must be registered in ACE specifically for refund purposes — separate from ACH enrollment for duty payments
• Entry list: a complete list of entry numbers with IEEPA duties paid, formatted as a CSV file per CBP’s CAPE Declaration template, available through the CAPE tab in ACE
• Authorization: only the IOR or the licensed customs broker who originally filed the entries can submit a CAPE Declaration for those entries

Early reports after the April 20 launch indicated some importers experienced technical difficulties accessing the portal and reaching CBP support. If you encounter issues, CBP’s trade support resources and your licensed customs broker are the appropriate channels for resolution.

Need Help with Your CAPE Filing?

Euro-American Worldwide Logistics’ licensed customs brokerage team is available to assist importers and IORs with identifying eligible entries, preparing CAPE Declarations, and navigating the ACE Portal filing process. If you have questions about your IEEPA refund eligibility or the CAPE submission process, contact us.

Every importer knows that the purchase price is not the cost of goods. What determines profitability — what sets the floor for pricing decisions, margin projections, and sourcing strategy — is landed cost: the total, all-in expense of moving a product from a supplier’s facility overseas to its final destination in the United States, fully cleared, compliant, and delivered.

Landed cost is not a single line item. It is a stack of charges that accumulates across every stage of the import process — some fixed by regulation, some variable by decision, and some avoidable entirely with the right planning. Importers who manage landed cost deliberately build more accurate pricing models, protect margins from unexpected erosion, and make better sourcing decisions. Those who treat it as an afterthought consistently encounter surprises they could have anticipated.

This guide breaks down every component of landed cost, explains what drives each one, and provides a practical framework for modeling, managing, and reducing total import cost across your supply chain.

What Is Landed Cost — and Why It Matters

Landed cost is the sum of every expense incurred from the moment goods are purchased from a foreign supplier to the moment they arrive at your facility, warehouse, or distribution point in the United States. It represents the true per-unit cost of imported goods — the number that should drive pricing decisions, not the factory price alone.

The gap between purchase price and landed cost is where margin surprises live. A product purchased at a cost that appears competitive can become unprofitable once duties, freight, fees, and handling are fully accounted for. Conversely, a supplier whose unit price appears higher may actually produce a lower landed cost when freight, duty rates, and compliance overhead are modeled correctly.

Landed cost is a strategic tool, not just an accounting exercise. Importers who model it accurately before placing purchase orders make better sourcing decisions than those who calculate it after goods arrive.

The components of landed cost fall into several distinct categories, each with its own drivers, variability, and optimization potential. The table below summarizes all major cost elements and their relative impact on total landed cost.

Component 1: Product Value and Customs Valuation

The declared customs value of imported goods is the foundation on which most other landed cost components are calculated. Duties are assessed as a percentage of customs value. The MPF and HMF are also value-based. Getting the customs value right is not just a compliance requirement — it directly determines the accuracy of every downstream cost calculation.

Transaction Value: The Primary Method

CBP uses transaction value — the price actually paid or payable for goods sold for export to the United States — as the preferred basis for customs valuation. In practice, this is the commercial invoice price. But the dutiable value is not always limited to the invoice price.

Importers must add the following to the transaction value when applicable:

• Assists: materials, components, tools, dies, molds, or engineering work provided by the buyer to the foreign seller free of charge or at reduced cost, used in the production of the imported goods. The value of assists must be added to the declared customs value
• Royalties and license fees: payments made as a condition of sale that relate to the imported merchandise must be included in dutiable value
• Proceeds of resale: any amount that accrues to the seller from subsequent resale of the goods that is not reflected in the invoice price
• Packing costs: the cost of containers and packing is included in customs value

Undervaluation Risk: Declaring a customs value lower than the actual transaction value — whether by omitting assists, understating royalties, or using non-arm’s-length pricing between related parties — constitutes customs fraud. CBP audits can examine entries up to five years after filing. The penalties for undervaluation are severe and include duties owed plus interest, civil penalties of up to four times the unpaid duties, and in egregious cases, criminal referral.

Incoterms and Their Effect on Customs Value

The terms of sale agreed between buyer and seller — defined by Incoterms — determine which costs are included in the invoice price and therefore in the dutiable customs value. This is a frequently overlooked driver of landed cost variation between suppliers.

Under CIF (Cost, Insurance, Freight) terms, the seller’s invoice includes freight and insurance to the destination port. Those costs are part of the dutiable value, meaning the importer pays duty on freight and insurance in addition to the product cost. Under FOB (Free on Board) terms, freight and insurance are arranged separately by the buyer and are generally not included in the dutiable value.

This distinction can meaningfully change the duty calculation on high-value or long-haul shipments. The table below summarizes how common Incoterms affect landed cost responsibility and customs valuation.

Component 2: Duties, Tariffs, and Trade Measures

Import duties represent one of the largest and most variable components of landed cost for most importers. They are determined by three factors acting in combination: the HTS classification of the product, the country of origin, and the applicability of any additional trade measures. Getting any one of these wrong produces an inaccurate landed cost model — and real financial exposure.

HTS Classification

The Harmonized Tariff Schedule assigns a 10-digit code to every product imported into the United States. The first six digits are internationally standardized; the final four digits are U.S.-specific and determine the applicable duty rate, regulatory requirements, and eligibility for preferential treatment under free trade agreements.

Classification is based on the product’s physical characteristics, material composition, essential function, and intended use — not on trade names, marketing descriptions, or what the seller calls the product. Small differences in composition or design can produce meaningfully different classifications, with correspondingly different duty rates.

Country of Origin

Country of origin is not the same as country of shipment. CBP determines origin based on where the goods were manufactured or, for goods involving multiple countries, where they underwent substantial transformation — a fundamental change in character, name, or use that results in a new and different article of commerce.

Origin matters for two reasons. First, it determines eligibility for preferential duty rates under free trade agreements such as USMCA, various bilateral FTAs, and programs like GSP (Generalized System of Preferences, where applicable). Second, it determines exposure to country-specific tariff measures.

Section 301 Tariffs (China-Origin Goods)

Section 301 tariffs impose additional duties — ranging from 7.5% to 100% depending on the product list — on goods of Chinese origin. These tariffs are layered on top of standard MFN duty rates and apply to a broad range of product categories. For importers sourcing from China, Section 301 exposure is typically the single largest duty cost driver and must be modeled at the product and HTS level, not estimated in aggregate.

Section 232 Tariffs

Section 232 tariffs apply to steel and aluminum products on national security grounds. The base rate is 25% on steel and 10% on aluminum, with country-specific exemptions and quota arrangements that change periodically. Importers of steel and aluminum — including downstream products with significant steel or aluminum content — must monitor Section 232 exposure carefully.

Antidumping and Countervailing Duties (AD/CVD)

Antidumping duties are assessed on foreign goods sold in the U.S. at less than fair value. Countervailing duties address foreign government subsidies that distort pricing. Both are product- and country-specific, administered by the Department of Commerce and ITC, and can be extremely high — in some cases exceeding 100% of the customs value.

AD/CVD Exposure: Antidumping and countervailing duty rates are set based on foreign producer margins and are subject to annual administrative review — meaning the rate at time of entry may not be the final rate. CBP can collect additional duties after liquidation if the review results in a higher rate. Importers buying from countries and product categories subject to AD/CVD orders should understand this retrospective exposure before establishing their landed cost model.

Component 3: Government Fees — MPF and HMF

Two government fees apply to nearly all commercial imports and should be treated as fixed, predictable components of every landed cost model. They are not negotiable, not avoidable, and frequently omitted from informal cost estimates.

Merchandise Processing Fee (MPF)

The MPF is assessed at 0.3464% of the declared customs value for formal entries, subject to a minimum of $32.71 and a maximum of $634.62 per entry. It applies to most formal entries regardless of mode of transport. Goods eligible for duty-free treatment under certain free trade agreements may also qualify for MPF exemption — another reason FTA eligibility analysis is worth performing at the SKU level.

Harbor Maintenance Fee (HMF)

The HMF is assessed at 0.125% of cargo value and applies to commercial cargo imported via ocean at U.S. ports. It does not apply to air freight shipments. The HMF is paid to the U.S. Army Corps of Engineers to fund harbor maintenance and dredging — and while modest, it should be included in every ocean import landed cost model.

Component 4: International Freight and Insurance

International freight is typically the largest variable cost in a landed cost model and the one most subject to market volatility, carrier capacity dynamics, and geopolitical disruption. Importers who treat freight as a static line item in their cost models consistently encounter margin surprises when market conditions shift.

Ocean Freight

Ocean freight remains the most cost-effective mode for high-volume, non-time-sensitive cargo. But the sticker rate — the base ocean freight charge quoted by the carrier — is only part of the cost picture. Ocean freight invoices typically include a range of surcharges and accessorial fees that must be captured in the landed cost model:

• Bunker Adjustment Factor (BAF): fuel surcharge that fluctuates with energy prices — significant during periods of oil price volatility
• Peak Season Surcharge (PSS): applied by carriers during high-demand shipping periods
• Port congestion surcharges: assessed when origin or destination ports are experiencing delays
• Terminal Handling Charges (THC): applied at origin and destination ports for container handling
• Documentation fees: bill of lading issuance and related administrative charges

Air Freight

Air freight is the mode of choice for time-sensitive, high-value, or temperature-sensitive cargo — categories that are especially common in life sciences supply chains. Air freight costs are calculated on chargeable weight, which is the greater of actual gross weight and volumetric weight (length x width x height in cm, divided by 6,000 for kilograms). For low-density products, volumetric weight frequently drives the cost calculation.

Fuel surcharges, security surcharges, and handling fees add to the base rate and must be included in the landed cost model. For pharmaceutical and biotech shipments requiring temperature-controlled handling, specialized container rental and dry ice replenishment costs add further to the air freight component.

Marine Insurance

Marine cargo insurance protects the value of goods in transit against loss, damage, or destruction. It is not legally required but is strongly recommended — particularly for high-value, temperature-sensitive, or fragile cargo. Premiums typically range from 0.5% to 1% of cargo value depending on commodity, mode, routing, and coverage terms. Under CIF Incoterms, the seller provides insurance — but importers should verify that the coverage terms and limits are adequate for their risk profile.

Component 5: Drayage, Domestic Freight, and Port Costs

The cost of moving goods from the port of arrival to the importer’s warehouse or distribution facility is consistently one of the most underestimated components of landed cost — particularly in environments of port congestion, chassis shortages, and elevated terminal fees.

Drayage

Drayage — the short-haul trucking movement from the marine terminal to a nearby warehouse or transloading facility — involves costs that extend well beyond the base trucking rate:

• Chassis fees: the cost of the wheeled trailer used to move the container from the terminal. Chassis availability is a persistent constraint at major U.S. ports and adds cost when split chassis or repositioning is required
• Port congestion fees: assessed by terminals when containers dwell beyond allocated free time due to port backup
• Pier pass and clean truck fees: applicable at certain West Coast ports as part of port authority programs
• Pre-pull charges: cost of moving a container from the terminal before the delivery appointment to avoid port fees

Demurrage and Detention

Demurrage and detention charges are among the most avoidable costs in international trade — and among the most expensive when they are not avoided. Demurrage is assessed by the ocean carrier when a container remains at the port terminal beyond the carrier’s free time allowance (typically three to five days). Detention is assessed when the importer retains the carrier’s container beyond the allowed free period for unpacking.

Avoidable Cost Alert: Demurrage and detention charges accumulate daily and can reach hundreds of dollars per container per day at major U.S. ports. They are almost entirely a function of documentation accuracy and logistics coordination. Shipments that arrive with complete, accurate entry documentation and a coordinated drayage plan clear faster and incur fewer — or no — detention and demurrage charges.

Managing Landed Cost: Fixed vs. Variable

Effective landed cost management begins with understanding which costs can be influenced and which must simply be planned around. The two categories require fundamentally different management approaches.

Fixed costs — duty rates, government fees, and tariff measures — are set by regulation and cannot be negotiated. But they can be managed through accurate classification that avoids overpayment, free trade agreement analysis that identifies preferential rate eligibility, and origin strategy that reduces tariff exposure where legally possible.

Variable costs — freight, routing, packaging, and timing — respond directly to planning quality and decision-making. The importers who consistently achieve lower landed costs are not the ones with lower duty rates — they are the ones who make better logistics decisions, maintain better documentation discipline, and avoid the avoidable costs that inflate everyone else’s landed cost model.

The best landed cost reduction strategy is accuracy: accurate classification prevents overpayment and audit exposure; accurate documentation prevents holds and demurrage; accurate planning prevents the reactive decisions that always cost more than proactive ones.

When Landed Costs Are Incurred

Landed cost components are not all paid at the same time. Understanding the payment sequence is essential for cash flow planning and for building an accurate picture of the capital requirements associated with an import program.

• Product cost: paid to the supplier per the agreed payment terms — typically in advance, at shipment, or against documents depending on the trade relationship and Incoterms
• International freight and insurance: typically paid to the freight forwarder before or at time of shipment; some carriers require pre-payment, others invoice after delivery
• Customs bond: continuous bond is an annual premium paid to the surety; single-entry bond premium is paid at time of entry
• Customs duties, MPF, and HMF: due within 10 days of cargo release under ACE payment; importers using Periodic Monthly Statement (PMS) consolidate duty payments monthly, improving cash flow
• Customs brokerage fees: typically invoiced after entry is filed and cleared
• Drayage and domestic freight: invoiced after delivery, typically within 30 days
• Demurrage and detention: invoiced by the carrier after the fact, often weeks after the shipment has cleared, making them easy to miss in initial landed cost accounting

For importers managing multiple concurrent shipments, the asynchronous nature of these payments can obscure the true landed cost of any individual entry. SKU-level landed cost tracking — where all costs associated with a specific shipment are captured and reconciled against the original estimate — is the standard of practice for importers who take cost management seriously.

How Euro-American Worldwide Logistics Supports Landed Cost Accuracy

At Euro-American Worldwide Logistics, we help importers build landed cost models that are accurate before the purchase order is placed — not estimates assembled after the fact from fragmented invoices. Our integrated platform combines licensed customs brokerage, international freight forwarding, and cGMP-compliant warehousing under one provider, which means we see the full cost picture of every shipment we handle.

That integration is not just operationally convenient. It produces better landed cost data. When classification, freight, brokerage, and warehousing are managed by separate providers, the cost information is fragmented across multiple invoices and systems. When they are managed together, the total landed cost of every shipment is visible in one place — and the decisions that affect it can be made with complete information.

• HTS classification and duty analysis: licensed customs brokers with expertise in pharmaceutical, biotech, medical device, and commercial import categories — ensuring classification accuracy that protects against both overpayment and audit exposure
• Tariff exposure assessment: Section 301, Section 232, AD/CVD, and free trade agreement eligibility analysis at the SKU level, before the sourcing decision is made
• Freight forwarding (air and ocean): full visibility into freight cost structures, including surcharges and accessorial fees, with routing strategies designed to optimize cost and transit time
• Customs bond management: selection, procurement, and ongoing monitoring of bond sufficiency as your import volume grows
• ISF filing and entry management: accurate, on-time filings that reduce inspection risk and prevent the documentation errors that generate holds, demurrage, and detention charges
• cGMP warehousing and distribution: temperature-validated storage and distribution for pharmaceutical, biotech, and medical device importers, integrated with customs clearance for seamless cargo flow from port to facility
• Post-entry compliance support: liquidation monitoring, post-entry amendment filing, and audit response support that protects your compliance record over the five-year CBP audit window

For life sciences companies where every dollar of landed cost affects product pricing, every day of delay affects patient access, and every compliance error affects regulatory standing — the difference between a transactional logistics vendor and an integrated partner is not marginal. It is material.

Conclusion

Landed cost is the number that actually determines whether an import program is profitable. It is built from a stack of components — some fixed, some variable, some avoidable — each of which responds to different management levers. Importers who understand those levers and apply them deliberately protect margins, make better sourcing decisions, and avoid the financial surprises that consistently erode profitability for those who do not.

The calculation is not complicated. What it requires is discipline: classifying accurately, modeling completely, documenting carefully, and coordinating logistics with the same precision that goes into product development and commercial planning. That discipline, applied consistently, is what separates landed cost management as a competitive advantage from landed cost accounting as an afterthought.

Euro-American Worldwide Logistics provides the expertise, infrastructure, and integrated visibility to help you control landed costs from origin to final delivery — accurately, reliably, and at every stage of your import program. Contact us today.

Most first-time importers underestimate the process. They understand, broadly, that goods need to clear customs. What they often do not anticipate is the sequence of regulatory requirements, documentation obligations, and agency reviews that must be completed — accurately, in order, and on time — before a single shipment is released into U.S. commerce.

The consequences of getting it wrong are not minor. Misclassified products, incomplete documentation, and missed filings produce delays, financial penalties, and in some cases, refused entry. For companies in regulated industries like pharmaceuticals, biotech, and medical devices, a customs error is rarely just a logistics problem — it can cascade into regulatory exposure, supply chain disruption, and reputational risk with the agencies that govern their products.

This guide walks through the ten steps every importer must complete to move goods into the United States compliantly. It is written for first-time importers who need a clear roadmap, and for experienced logistics teams who want a structured reference they can put to work.

At a Glance: The 10-Step Import Compliance Checklist

Step 1: Obtain an Importer Identification Number

Before a single entry can be filed with CBP, the importing entity must have a valid identification number on record. This is not a formality — it is a legal prerequisite that determines who is accountable for the shipment and how CBP tracks compliance history.

The three acceptable forms of importer identification are:

• Employer Identification Number (EIN): the standard identifier for U.S. businesses, issued by the IRS and used to establish the importer’s compliance record with CBP
• Social Security Number (SSN): used by individuals importing goods without a formal business entity
• CBP-assigned number: available to foreign importers who do not have a U.S. EIN or SSN, issued directly by CBP upon application

If your business does not already have an EIN, obtaining one should be the first action item before any supplier negotiation concludes. CBP registration using CBP Form 5106 is completed by your customs broker and establishes your importer profile in ACE — the Automated Commercial Environment that processes all U.S. customs entries.

Your importer identification number is the foundation of your compliance record. Every entry you file, every duty you pay, and every inspection outcome is associated with it. Starting that record accurately matters.

Step 2: Define the Importer of Record

The Importer of Record (IOR) is the legal entity responsible for a shipment’s compliance with all applicable U.S. laws and regulations. That responsibility includes filing accurate entry documentation, paying all applicable duties and fees, and maintaining the records CBP may request during a post-entry audit.

This distinction matters more than most first-time importers realize. The IOR is not automatically your supplier, your freight forwarder, or your customs broker. It is the party who owns the compliance obligation — and the penalty exposure when something goes wrong.

Common IOR structures include:

• The U.S. buyer or consignee: the most common structure, where the domestic purchaser assumes IOR responsibility as part of the commercial transaction
• A foreign seller operating as IOR: possible under certain trade terms but operationally complex and less common
• A third-party IOR service provider: used when the buyer cannot or does not want to hold IOR status directly, though this introduces contractual complexity and cost

Defining the IOR before the first shipment moves — and documenting it clearly in your supply agreements — is not a bureaucratic exercise. It is the baseline of a defensible compliance program.

Step 3: Secure a Customs Bond

A customs bond is a financial guarantee to CBP that the importer will fulfill all legal obligations associated with the entry — including accurate declaration, duty payment, and compliance with any additional regulatory requirements. Without a bond in place, formal entry cannot be filed for shipments that require one.

The bond threshold applies to any shipment valued at $2,500 or more, goods regulated by a federal agency regardless of value, and any commercial shipment entering U.S. commerce. In practice, nearly all commercial import programs require a bond.

Bond Types

Single-entry bond: Covers one specific shipment. Appropriate for infrequent or one-time importers, but carries a higher cost per transaction and requires a new bond for every entry.

Continuous bond: Covers all entries for a 12-month period. The standard choice for any importer with regular shipment volume. The bond amount is set at 10% of the total duties, taxes, and fees paid in the prior year, with a minimum of $50,000.

Your customs broker manages the bond on your behalf and will advise on the appropriate bond type and amount based on your import program. Bond sufficiency is monitored by CBP, and an insufficient bond can result in additional security requirements or entry restrictions.

Step 4: Confirm Product Admissibility

Not every product is freely admissible into the United States. A significant number of product categories are subject to additional oversight from Partner Government Agencies (PGAs) — federal bodies that regulate their specific industries and whose requirements must be satisfied before CBP will release a shipment.

Confirming admissibility before shipping is not optional. Discovering a PGA requirement after goods have arrived at a U.S. port — without the required permits, registrations, or documentation — results in holds, detention, and in some cases, refusal of admission and destruction of cargo at the importer’s expense.

Key PGA agencies and their jurisdictions include:

• FDA (Food and Drug Administration): food, pharmaceuticals, biologics, medical devices, cosmetics, and dietary supplements. FDA-regulated products require facility registration, prior notice for food shipments, and in many cases, specific import alerts or compliance documentation
• USDA / APHIS (Animal and Plant Health Inspection Service): agricultural commodities, biological materials, animal products, and wood packaging. Phytosanitary certificates and treatment documentation are commonly required
• FCC (Federal Communications Commission): electronics, radio frequency devices, and telecommunications equipment. FCC authorization or labeling is required before entry
• CPSC (Consumer Product Safety Commission): children’s products, general consumer goods, and products subject to mandatory safety standards
• ATF (Bureau of Alcohol, Tobacco, Firearms and Explosives): firearms, ammunition, explosives, and alcohol products. Import licenses and permits are required
• EPA (Environmental Protection Agency): vehicles, engines, pesticides, and products subject to environmental regulations

For life sciences importers, FDA admissibility is not a one-time check. It is an ongoing compliance obligation tied to facility registration, product classification, and the regulatory status of every item in your import program.

Step 5: Classify Your Products Under the HTS

Every product imported into the United States must be assigned a 10-digit Harmonized Tariff Schedule (HTS) code. This classification is not a formality — it is the mechanism by which CBP determines the applicable duty rate, identifies tariff exposure, flags additional regulatory requirements, and assesses eligibility for preferential trade programs.

HTS classification is based on the product’s physical characteristics, material composition, function, and intended use — not on how the product is marketed or what the seller calls it. Two products that appear similar but differ in material or function may carry meaningfully different HTS codes, with correspondingly different duty rates and regulatory treatment.

Classification Risk: A misclassified HTS code is one of the most common and costly errors in international trade. It can result in underpayment of duties (creating liability during CBP audit), overpayment of duties (eroding margin unnecessarily), antidumping and countervailing duty exposure that was not anticipated, and loss of eligibility for free trade agreement benefits. CBP can audit entries up to five years after filing.

Classification should be performed by a licensed customs broker with expertise in your product category. For importers with complex or novel products — such as combination drug-device products, advanced biologics, or emerging biotech materials — a binding ruling request to CBP provides a legally authoritative classification determination that protects against future challenge.

Step 6: Estimate Total Landed Cost Before the Shipment Moves

Landed cost is the true cost of an imported product: everything required to get it from the supplier’s facility to your receiving dock, fully cleared and compliant. Importers who plan around product cost alone — without modeling the full landed cost — consistently encounter margin erosion, pricing miscalculations, and financial surprises that could have been avoided.

The components of total landed cost include:

• Product cost and declared customs value: the transaction value, which forms the basis for ad valorem duty calculation
• International freight and insurance: ocean or air freight cost plus marine insurance, both of which may be included in the dutiable value depending on the terms of sale
• Import duties: based on HTS classification, country of origin, and applicable tariff programs including Section 301, Section 232, and antidumping/countervailing duties
• Merchandise Processing Fee (MPF): 0.3464% of cargo value, subject to a minimum of $32.71 and a maximum of $634.62 per entry
• Harbor Maintenance Fee (HMF): 0.125% of cargo value, assessed on ocean shipments arriving at U.S. ports
• Customs brokerage and entry fees: professional fees for classification, entry filing, and clearance coordination
• Domestic freight and final delivery: drayage, trucking, and last-mile delivery to your facility or distribution point
• Warehousing and handling: applicable if goods require bonded storage, inspection, or repackaging before final distribution

A landed cost model built before the purchase order is placed is a pricing tool. A landed cost calculation done after the shipment arrives is an accounting exercise — one that often reveals problems too late to fix.

Step 7: Complete a Pre-Shipment Compliance Review

The most cost-effective point to find and fix a compliance problem is before the goods leave the supplier. Once a shipment is in transit, the options narrow. Once it arrives at a U.S. port, the leverage disappears entirely. A structured pre-shipment review is the standard of practice for experienced importers — and it is the single highest-return compliance investment available.

A thorough pre-shipment review confirms:

• HTS classification accuracy: verify that the assigned code matches the product’s actual characteristics, not its commercial description
• Declared customs value: confirm that the transaction value is accurate, complete, and consistent with the commercial invoice
• Country of origin: verify through supplier documentation that the origin declaration is accurate and supportable under CBP’s substantial transformation rules
• PGA documentation: confirm that all required permits, registrations, certificates, and prior notices are in place before loading
• Commercial invoice completeness: verify that the invoice contains all required data elements in the format CBP and PGAs require
• Packing list accuracy: confirm that the packing list matches the commercial invoice and reflects the actual contents of each container
• Wood packaging compliance: if applicable, confirm ISPM-15 treatment certification for all wood packaging materials

For importers in the life sciences, pre-shipment review should also include verification of cold chain packaging qualification, temperature monitoring device calibration, and FDA facility registration status for both the shipper and any registered establishments associated with the product.

Step 8: File the ISF and Coordinate Freight Documentation

Logistics execution and compliance documentation must move in parallel. A well-coordinated shipment is one where the freight is booked, the ISF is filed, and all documentation is assembled before the cargo reaches the origin port.

Importer Security Filing (ISF 10+2) — Ocean Freight

The ISF must be submitted to CBP at least 24 hours before cargo is loaded onto the vessel at origin. It requires ten data elements from the importer — including buyer and seller information, manufacturer details, country of origin, and HTS classification — and two additional elements from the ocean carrier.

Penalty Exposure: Late ISF filings, missing data elements, and inaccurate information each constitute separate violations carrying fines of up to $5,000. CBP also uses ISF compliance history as an input into shipment risk scoring — meaning a pattern of ISF errors increases inspection rates across your entire import program.

Core Entry Documentation

Regardless of mode, every entry requires a complete and consistent documentation package:

• Commercial invoice: seller’s declaration of the goods, their value, and the terms of sale — must include all CBP-required data elements
• Packing list: detailed breakdown of contents, weights, and measurements by carton or container
• Bill of lading (ocean) or airway bill (air): the carrier’s contract of carriage and evidence of shipment
• Customs bond: must be active and of sufficient value to cover the entry
• PGA documentation: any certificates, permits, prior notices, or registration confirmations required by applicable agencies

Discrepancies between any of these documents — inconsistent quantities, mismatched values, conflicting country of origin declarations — are among the most common triggers for CBP holds and manual review.

Step 9: Navigate CBP Entry Review and Cargo Release

When your shipment arrives at a U.S. port of entry, CBP reviews all submitted documentation and applies risk-scoring models to determine how the entry will be processed. The majority of well-documented shipments from established importers clear without inspection. But the process is not passive — it rewards preparation and penalizes gaps.

Possible Entry Outcomes

• Immediate release: CBP accepts the entry as filed. Duties are assessed and the shipment is released to the importer.
• Request for additional information (CF-28): CBP requests clarification on classification, valuation, or origin. A timely, accurate response typically resolves the matter without escalation.
• Proposed rate advance (CF-29): CBP proposes a change to the declared duty rate — most commonly due to classification or valuation disagreement. The importer can protest or accept.
• Examination or hold: CBP physically inspects the shipment or issues a hold pending additional documentation or agency review. This is when an experienced customs broker’s relationships and response speed matter most.

Following release, the Entry Summary (CBP Form 7501) must be filed within 10 days. This is the formal accounting of all duties owed and is the document CBP uses to liquidate the entry — the point at which the final duty liability is legally established.

Cargo release is not the end of the compliance process. It is the beginning of the post-entry phase, which carries its own obligations, deadlines, and audit risk.

Step 10: Maintain Post-Entry Compliance and Records

CBP’s authority does not end when your shipment is released. Under 19 U.S.C. §1508, importers are required to maintain all records related to an importation for a minimum of five years from the date of entry. This includes commercial invoices, packing lists, bills of lading, classification worksheets, correspondence with suppliers, and any documents submitted to or received from CBP or PGAs.

Post-entry compliance obligations also include:

• Monitoring liquidation status: CBP has up to one year from entry to liquidate, and importers should track liquidation notices to identify unexpected duty changes or rate advances
• Filing post-entry amendments: if an error is discovered after release, a prior disclosure or post-entry amendment can reduce or eliminate penalty exposure — but only if filed voluntarily before CBP initiates an inquiry
• Responding to CBP audits: CBP’s Regulatory Audit division conducts focused assessments and comprehensive audits of importer compliance programs. A five-year record of clean, well-documented entries is the foundation of a defensible response
• Maintaining country of origin documentation: supplier certifications and origin evidence must be retained and kept current, particularly as supply chain structures evolve
• Monitoring tariff and regulatory changes: HTS rates, Section 301 lists, antidumping orders, and PGA requirements change. Importers whose classification and compliance work is static — not updated as the regulatory environment shifts — accumulate exposure over time

The importers who fare best in CBP audits are the ones who treat compliance as a continuous program, not a one-time event. Five years of well-maintained records is the difference between a routine review and a significant disruption.

How Euro-American Worldwide Logistics Supports the Full Import Process

Importing into the United States is a compliance-intensive process that requires expertise at every step — from initial registration through post-entry recordkeeping. At Euro-American Worldwide Logistics, we provide the full spectrum of customs brokerage, freight forwarding, and logistics support that importers need to execute this process accurately and efficiently.

Our customs brokerage division — led by Karen A. Busenburg, the first female licensed Customs Broker in Massachusetts and one of the first five in the United States — brings more than 70 combined years of brokerage experience to every entry we handle. That expertise is not theoretical. It is applied to every classification decision, every filing, and every hold we work to resolve on behalf of our clients.

• Importer setup and CBP registration (Form 5106): establishing your importer profile accurately in ACE from day one
• HTS classification and regulatory review: product-level classification by licensed brokers with expertise in life sciences, industrial, and commercial import categories
• Customs bond management: selection, procurement, and monitoring of bond sufficiency as your import program grows
• ISF filing and pre-shipment compliance: accurate, on-time ISF submissions that establish a clean compliance record with CBP
• Entry preparation and CBP coordination: complete entry documentation, proactive hold management, and direct CBP liaison when issues arise
• PGA coordination: FDA, USDA, FCC, and other agency filings managed as part of the clearance process, not as an afterthought
• Post-entry compliance support: liquidation monitoring, post-entry amendments, and audit response assistance
• Integrated freight and warehousing: our brokerage is part of a fully integrated 3PL platform that includes air and ocean freight forwarding, cGMP-compliant warehousing, and final-mile delivery

For life sciences companies where import compliance intersects with FDA regulatory obligations, product integrity requirements, and supply chain continuity — an integrated partner who understands both the logistics and the regulatory environment is not a convenience. It is a strategic necessity.

Conclusion

Importing into the United States is a structured, regulated process that rewards careful preparation and penalizes shortcuts. Each of the ten steps in this guide exists for a reason — and each one carries real consequences when executed poorly.

The importers who build efficient, compliant import programs are not the ones who figured it out as they went. They are the ones who invested in accurate classification, clean documentation, and experienced partners before the first shipment moved — and who treat compliance as an ongoing program rather than a one-time project.

Euro-American Worldwide Logistics delivers the expertise, infrastructure, and oversight needed to build a compliant, efficient import program from the ground up — and to keep it running as your business and the regulatory environment evolve. Contact us today!

In today’s pharmaceutical landscape, supply chains are more complex, more regulated, and more critical to product success than ever before. As biologics, cell and gene therapies, and temperature-sensitive products continue to dominate development pipelines, manufacturers are reevaluating how they manage logistics, compliance, and storage.

While large global logistics providers have traditionally led the market, a growing number of pharmaceutical companies are finding greater value in smaller, specialized third-party logistics (3PL) providers. These niche partners offer integrated, all-in-one solutions—combining international shipping, customs brokerage, and cGMP-compliant warehousing into a single, coordinated platform.

The Complexity of Modern Pharma Supply Chains

Pharmaceutical logistics now extends far beyond transportation and storage. Today’s supply chains must meet strict regulatory requirements, maintain temperature integrity, ensure product traceability, and navigate global trade complexities.

Manufacturers must manage cGMP and GDP standards, customs compliance, documentation accuracy, and risk mitigation for high-value products. Coordinating these requirements across multiple vendors can introduce delays, miscommunication, and compliance risk.

The Value of an Integrated 3PL Model

Niche 3PL providers address these challenges by integrating core logistics functions into a unified solution. By combining freight forwarding, customs brokerage, and GMP-compliant storage, they reduce handoffs and streamline communication.

This approach improves operational efficiency and enhances visibility across the supply chain. Instead of managing separate providers, manufacturers gain a single point of accountability and a more coordinated logistics strategy.

Improved Visibility and Control

Consolidating logistics services under one provider gives manufacturers greater control over their supply chains. Real-time tracking, consistent processes, and centralized communication reduce uncertainty and enable faster response to disruptions.

In an industry where product integrity and compliance are critical, this level of oversight supports better decision-making and reduces operational risk.

Regulatory Expertise Built Into Operations

Pharmaceutical logistics operates within a highly regulated environment. Niche 3PL providers specializing in life sciences embed regulatory expertise into their daily operations, ensuring compliance is proactive rather than reactive.

Integrated customs brokerage services further strengthen this model by reducing delays and improving documentation accuracy. This helps prevent costly shipment holds, penalties, or product loss.

Flexibility and Scalability

Unlike larger providers that rely on standardized processes, niche 3PLs offer greater flexibility. They can adapt to changing requirements, including clinical trial logistics, product launches, and fluctuating demand.

This scalability allows pharmaceutical companies to expand operations without significant capital investment in infrastructure.

Specialized Cold Chain Infrastructure

Temperature control remains one of the most critical aspects of pharmaceutical logistics. Niche providers often invest in specialized infrastructure, including validated temperature ranges, continuous monitoring systems, and redundant safeguards.

These capabilities ensure that temperature-sensitive products are handled with precision, reducing the risk of excursions and maintaining product integrity.

A More Collaborative Partnership

Smaller, specialized 3PL providers often operate as strategic partners rather than transactional vendors. This results in more direct communication, tailored solutions, and a deeper understanding of client operations.

For pharmaceutical manufacturers, this collaborative approach supports more effective logistics planning and execution.

A Euro-American Worldwide Logistics Perspective

At Euro-American Worldwide Logistics, we see this shift firsthand. Life science manufacturers are no longer looking for fragmented logistics services—they are seeking integrated partners who understand the full scope of their supply chain requirements.

Our approach combines cGMP-compliant warehousing, licensed U.S. Customs Brokerage, and global freight forwarding into a single, unified solution. This allows our clients to reduce complexity, improve compliance, and maintain full visibility across their operations.

With our Massachusetts-based facility and deep expertise in life sciences logistics, we support pharmaceutical and biotech companies with infrastructure and processes designed specifically for regulated products—ensuring precision, reliability, and peace of mind.

Let’s Start the Conversation

If your organization is evaluating how to streamline logistics, improve compliance, or scale operations without increasing internal complexity, Euro-American Worldwide Logistics is ready to help.

Contact our team today to learn how our integrated 3PL solutions can support your pharmaceutical supply chain.